LOW GRADE NON-HODGKIN'S LYMPHOMA, ADULT
Clinical trials for LOW GRADE NON-HODGKIN'S LYMPHOMA, ADULT explained in plain language.
Never miss a new study
Get alerted when new LOW GRADE NON-HODGKIN'S LYMPHOMA, ADULT trials appear
Sign up with your email to follow new studies for LOW GRADE NON-HODGKIN'S LYMPHOMA, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to control lymphoma without lifelong drugs
Disease control Recruiting nowThis study tests whether combining two drugs, epcoritamab and rituximab, can effectively treat follicular lymphoma in people who haven't had treatment before. About 100 adults with this slow-growing blood cancer will receive the drug combination. The goal is to see if the cancer …
Matched conditions: LOW GRADE NON-HODGKIN'S LYMPHOMA, ADULT
Phase: PHASE2 • Sponsor: Reid Merryman, MD • Aim: Disease control
Last updated May 17, 2026 06:08 UTC
-
New study tracks quality of life in elderly lymphoma patients
Knowledge-focused Recruiting nowThis study follows 150 elderly patients (70 years or older) with low-grade non-Hodgkin lymphoma to see how their quality of life changes during treatment. Researchers will use questionnaires to measure well-being and symptoms at the start, end, and one year after therapy. The goa…
Matched conditions: LOW GRADE NON-HODGKIN'S LYMPHOMA, ADULT
Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Knowledge-focused
Last updated May 17, 2026 06:08 UTC